Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2026-03-11 @ 11:58 AM
Study NCT ID:
NCT02614066
Status:
COMPLETED
Last Update Posted:
2024-11-19
First Post:
2015-11-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Sponsor:
Kite, A Gilead Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KTE-C19-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None